Webinar Tuesday November 10th: Equal and better care for everyone
Q-linea AB (publ) (OMX: QLINEA), invites you to a webinar with presentations followed by a Q&A session by CEO Jonas Jarvius, Research Director Mats Gullberg and Marketing & Sales Director Charlotta Göransson.
Date: November 10th
Time: 17.00 CET, 11 AM EDT, 8 AM PDT
Duration: 1 hour
On the agenda:
- How ASTar meets the challenges in the lab and clinic, and help improve patient outcomes
- Sneak peek on an upcoming exciting product
- Q&A session - get answers to your questions
Learn more and register here:
A link to the webinar will be sent out closer to the date. If you have not received an email containing the link at least two hours prior to the webcast, check your junk mail. If the email still cannot be found, please email Oskar Alsing (email@example.com).
The webinar will be available afterwards on-demand if you do not have the opportunity to join.
For more information, please contact:
Jonas Jarvius, CEO, Q-linea AB
+46 (0)70-323 77 60
Charlotta Göransson, Sales & Marketing Director, Q-linea AB
+46 (0)70-771 59 67
The information was submitted for publication, through the agency of the contact persons set out above, at 13:00 CET on October 28, 2020.
Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company’s lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.